References
- Owen MJ, Craddock N, O’donovan MC. Schizophrenia: genes at last?. Tren Gen. 2005;21(9):518–525.
- Giegling I, Hartmann AM, Genius J, et al. Systems biology and complex neurobehavioral traits. Pharmacopsychiat. 2008;41(S 01):S32–S36.
- Kieseppa T, Partonen T, Haukka J, et al. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry. 2004;161(10):1814–1821.
- Gatz M, Pedersen NL, Berg S, et al. Heritability for Alzheimer’s disease: the study of dementia in Swedish twins. The J. Gerontol. Ser A: Biol Sci Med Sci. 1997;2(2):M117–M125.
- Pinto LA, Stein RT, Kabesch M. Impact of genetics in childhood asthma. J Pediatr. 2008;84(4):S68–S75.
- Locatelli I, Rosina A, Lichtenstein P, et al. A correlated frailty model with long term survivors for estimating the heritability of breast cancer. Statist Med. 2007;26(20):3722–3734.
- Craddock N, O’donovan MC, Owen MJ. Phenotypic and genetic complexity of psychosis: invited commentary on Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry. 2007;190(3):200–203.
- Stefansson H, Steinthorsdottir V, Thorgeirsson T, et al. Neuregulin 1 and schizophrenia. Ann Med. 2004;36(1):62–71.
- Gaspar PA, Bustamante ML, Silva H, et al. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications. J Neurochem. 2009;111(4):891–900.
- Corfas G, Roy K, Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci. 2004;7(6):575.
- Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10(1):40.
- Sastry GM, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27(3):221–234.
- Singh T, Biswas D, Jayaram B, et al. AADS-An automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors. J Chem Inf Model . 2011; 51(10):2515–2527.
- Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791.
- Yuan S, Chan HS, Filipek S, et al. PyMOL and Inkscape bridge the data and the data visualization. Structure. 2016; 24(12):2041–2042.
- Vistoli G, Pedretti A, Testa B. Assessing drug-likeness–what are we missing? Drug Disc Today. 2008;13(7–8):285–294.
- Kumari MA, Rao CV, Triloknadh S, et al. Synthesis, docking and ADME prediction of novel 1, 2, 3-triazole-tethered coumarin derivatives as potential neuroprotective agents. Res Chem Intermed. 2018; 44(3):1989–2008.
- Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–1612.
- Zhao YH, Abraham MH, Le J, et al. Rate-limited steps of human oral absorption and QSAR studies. Pharmaceu Res. 2002;19(10):1446–1457.
- Walkinshaw G, Waters CM. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience. 1994;63(4):975–987.